Dysferlin, Annexin A1, and Mitsugumin 53 Are Upregulated in Muscular Dystrophy and Localize to Longitudinal Tubules of the T-System With Stretch

Leigh B. Waddell(Children's Hospital at Westmead), Sandra T. Cooper(The University of Sydney), J. Hawkes(Mayo Clinic), Kathryn N. North(The University of Sydney), Frances A. Lemckert(The University of Sydney), Xi Zheng(Guangdong University of Technology), Jenny Tran(Mayo Clinic), Angela Lek(Muscular Dystrophy Association), Michael J. Ackerman(Mayo Clinic in Florida), Nigel F. Clarke(The University of Sydney), Noah Weisleder(The Ohio State University), Jianjie Ma(Society of Critical Care Medicine), Frances J. Evesson(Harvard University), Neil Street(Mayo Clinic), Andrew P. Landstrom(Mayo Clinic)
Journal of Neuropathology & Experimental Neurology
March 16, 2011
10.1097/nen.0b013e31821350b0
Cited by 110

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|899
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
|Science Translational Medicine|2017|805
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
|Nature Genetics|2007|702
Integrating Genomics into Healthcare: A Global Responsibility
|The American Journal of Human Genetics|2019|390
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy
|New England Journal of Medicine|2023|302